Skip to content
Oncology Research Hub

Massachusetts

Cancer clinical trials in Massachusetts

503 cancer studies are recruiting participants at sites in 31 cities across Massachusetts as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Massachusetts city with a recruiting study

By research area: Breast Cancer (152), Lung Cancer (143), Lymphoma (108), Prostate Cancer (53), Pancreatic Cancer (27), Melanoma (20).

Boston (467), Worcester (28), Burlington (24), Springfield (14), Peabody (13), Foxborough (11), Beverly (10), Methuen (10), Milford (10), South Weymouth (10), Gloucester (9), Newton (7), Brighton (5), Stoneham (5), Lowell (4), Weymouth (4), Winchester (4), Newburyport (3), Danvers (2), Plymouth (2), Brookline (1), Fairhaven (1), Fall River (1), Holyoke (1), Hyannis (1), Jamaica Plain (1), Pittsfield (1), Salem (1), Wellesley Hills (1), Woburn (1), Worester (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Massachusetts

Basic details from each study's public record (the 12 most recently updated of 503). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Boston
    Registry record
    NCT06324357 · updated
  2. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Boston
    Registry record
    NCT06686394 · updated
  3. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    LeonaBio
    Recruiting in
    Boston
    Registry record
    NCT05696626 · updated
  4. A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Boston
    Registry record
    NCT05894239 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Massachusetts on ClinicalTrials.gov.

Lung cancer: recently updated in Massachusetts

  1. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Boston
    Registry record
    NCT06983743 · updated
  2. A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

    • Phase 3
    • Ages 18 to 100
    • All sexes
    Sponsor
    Amgen
    Recruiting in
    Worcester
    Registry record
    NCT05920356 · updated
  3. EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

    • No phase
    • Ages 40 to 80
    • All sexes
    Sponsor
    Dana-Farber Cancer Institute
    Recruiting in
    Boston
    Registry record
    NCT06716580 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Massachusetts on ClinicalTrials.gov.

Prostate cancer: recently updated in Massachusetts

  1. The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

    • No phase
    • Ages 55 to 69
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Boston
    Registry record
    NCT05926102 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Massachusetts on ClinicalTrials.gov.

Melanoma: recently updated in Massachusetts

  1. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Boston
    Registry record
    NCT02332668 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Massachusetts on ClinicalTrials.gov.

Lymphoma: recently updated in Massachusetts

  1. A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

    • No phase
    • Ages 1 to 25
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Boston
    Registry record
    NCT05621291 · updated
  2. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Boston
    Registry record
    NCT06806033 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Massachusetts on ClinicalTrials.gov.

Ask about studies in Massachusetts

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call